AU
RMD icon

AlphaGrep UK’s ResMed RMD Stock Holding History

AlphaGrep UK’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$544K Buy
2,794
+191
+7% +$39.6K 0.16% 199
2026
Q1 		$584K Buy
2,603
+189
+8% +$47.1K 0.17% 171
2025
Q4 		$581K Buy
+2,414
New +$617K 0.19% 162

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

AlphaGrep UK's RMD Position: Q2 2026 in Review

AlphaGrep UK increased its ResMed (RMD) stake by 7.3% in Q2 2026, buying an estimated $39.6K and bringing the position to 2,794 shares worth $544K. The position accounts for 0.16% of the portfolio, ranked #199.

AlphaGrep UK first reported a position in RMD in Q4 2025 and has held it in 3 quarters since. The position peaked at $584K in Q1 2026. 836 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • AlphaGrep UK held 2,794 shares of ResMed worth $544K as of Q2 2026.
  • AlphaGrep UK bought 191 ResMed shares in Q2 2026, an estimated $39.6K.
  • ResMed made up 0.16% of AlphaGrep UK's portfolio in Q2 2026, its #199 holding.
  • AlphaGrep UK first reported a position in ResMed in Q4 2025 and has held it in 3 quarters since.
  • AlphaGrep UK's ResMed position peaked at $584K in Q1 2026.
  • 836 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on AlphaGrep UK's 13F filing for Q2 2026, filed 14 Aug 2026.